CN107929592A - A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof - Google Patents
A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof Download PDFInfo
- Publication number
- CN107929592A CN107929592A CN201711341897.4A CN201711341897A CN107929592A CN 107929592 A CN107929592 A CN 107929592A CN 201711341897 A CN201711341897 A CN 201711341897A CN 107929592 A CN107929592 A CN 107929592A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- hepatitis
- medicine composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof, the Chinese medicine composition of the treatment hepatitis A are prepared by the Chinese medicine material medicine of following weight proportion：Wild 8 12 grams of cigarette, 8 12 grams of Artemisia stelleriana, 8 12 grams of wild leek, 8 12 grams of babysbreath, 8 12 grams of giant knotweed, 8 12 grams of Common Goldenrod Herb, 5 80 grams of leftovers.Present invention additionally comprises a kind of preparation method for the Chinese medicine composition for treating hepatitis B.The Chinese medicine composition for the treatment of hepatitis A of the present invention, can effectively treat hepatitis A, curative effect is clear and definite, and therapeutic effect is good；The Chinese medicine composition for the treatment of hepatitis A of the present invention is pure Chinese medicine product, for the Western medicine of other treatment hepatopathy, Small side effects, and the basic fanout free region of patient and pain.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for treating hepatitis A and preparation method thereof.
Background technology
Hepatitis A is by hepatitis A virus（HAV）Caused a kind of virus hepatitis, mainly through excrement mouth（Or anus mouth）Propagate way
Footpath is infected, and passes through the hepatitis A virus of transmission（Abbreviation hepatitis A virus）And cause a disease, i.e. the incubation period by patient or urgency
Hepatitis A virus polluted source, food, apparatus and life close contact in property phase excrement, blood are passed transorally into intestines and stomach and pass
Broadcast.Hepatitis A virus has various extraneous factors stronger resistance and can survive for a long time in external environment, can pass through various dirts
Contaminate article hand, articles for daily use, clothing, coverlet etc.）And water and food transmission, it can also carry and propagate through fly.Hepatitis A patient
Clinical manifestation be：Generate heat weak, apocleisis, detest oil, icteric sclera, hepatalgia, liver enlargement, liver function index extremely rise
Height, small number of patients are also possible to make renal function exacerbation oedema or encephaledema, liver function deterioration occur, or even dead.
At present, it is many to treat the Western medicine of hepatitis A, general patient is using inosine, vitamin C, liver-protecting tablet etc., though have certain
Curative effect, but there are the deficiencies of the course for the treatment of is long, side effect is big and easily recurs.
The content of the invention
The technical problem to be solved by the invention is to provide a kind of curative effect is clear and definite, in the good treatment hepatitis A of therapeutic effect
Drug composition and preparation method thereof.
The technical solution adopted by the present invention to solve the technical problems is：
The Chinese medicine composition of the treatment hepatitis A of the present invention, includes the component of following weight proportion：
Wild 8-12 grams of cigarette, sub- 8-12 grams of Artemisia stelleriana, 8-12 grams of wild leek, 8-12 grams of babysbreath, 8-12 grams of giant knotweed, Common Goldenrod Herb 8-12
Gram, 5-80 grams of leftovers.
Preferably, wild 9-11 grams of cigarette, it is furthermore preferred that wild 10 grams of cigarette.
Preferably, sub- 9-11 grams of Artemisia stelleriana, it is furthermore preferred that 10 grams of Artemisia stelleriana.
Preferably, 9-11 grams of wild leek, it is furthermore preferred that 10 grams of wild leek.
Preferably, 9-11 grams of babysbreath, it is furthermore preferred that 10 grams of babysbreath.
Preferably, 18-22 grams of giant knotweed, it is furthermore preferred that 20 grams of giant knotweed.
Preferably, 9-11 grams of Common Goldenrod Herb, it is furthermore preferred that 10 grams of Common Goldenrod Herb.
Preferably, 10-60 grams of leftovers, it is furthermore preferred that 45 grams of leftovers.
Carry out source problem on raw material：Wild cigarette root, Artemisia stelleriana son root skin, wild leek seed, babysbreath root, leaf, giant knotweed
Root skin, Common Goldenrod Herb leaf, is dried.
Leftovers：With text fried dry moisture living.
Processing of crude drugs:Dry, break into powder.
The preparation method of the Chinese medicine composition of the treatment hepatitis A of the present invention, is：Each raw material first is weighed by predetermined weight proportioning,
Then distinguish grinds, be uniformly mixed, you can.
Wild cigarette：Light, flat, the eliminating inflammation and expelling toxin of property.
Artemisia stelleriana：Property hardship is salty, reducing fever and causing diuresis.
Wild leek：Property is done, is salty, homoiothermy regulating the qi flowing in the channels.
Babysbreath：Flat, pungent, heat-clearing, diuresis, resolving sputum.
Giant knotweed：It is salty, light, it is clearing heat and detoxicating.
Common Goldenrod Herb：It is pungent, light, promoting blood circulation dispelling cold, resolving sputum.
Mountain Auricled Hedyotis Herb：Alkali, pungent, anti-inflammation and sterilization.
Usage and dosage：It is oral, 3 times a day, 2 grams every time.
Beneficial effects of the present invention：The Chinese medicine composition for the treatment of hepatitis A of the present invention, can effectively treat hepatitis A, treat
Effect is clear and definite, and therapeutic effect is good；The Chinese medicine composition for the treatment of hepatitis A of the present invention is pure Chinese medicine product, relative to other treatment
For the Western medicine of hepatopathy, Small side effects, the basic fanout free region of patient and pain.
Embodiment
The invention will be further described with reference to embodiments.
Embodiment 1
The Chinese medicine composition of the treatment hepatitis A of the present embodiment, includes the component of following weight proportion：
Wild 9 grams of cigarette, 11 grams of Artemisia stelleriana, 11 grams of wild leek, 9 grams of babysbreath, 18 grams of giant knotweed, 11 grams of Common Goldenrod Herb, 10 grams of leftovers.
Preparation method, is：Each raw material first is weighed by predetermined weight proportioning, then grinds respectively, is uniformly mixed, you can.
Usage and dosage：It is oral, 3 times a day, 2 grams every time.
Embodiment 2
The Chinese medicine composition of the treatment hepatitis A of the present embodiment, includes the component of following weight proportion：
Wild 11 grams of cigarette, 9 grams of Artemisia stelleriana, 91 grams of wild leek, 11 grams of babysbreath, 22 grams of giant knotweed, 9 grams of Common Goldenrod Herb, 60 grams of leftovers.
Preparation method and usage and dosage are the same as embodiment 1.
Embodiment 3
The Chinese medicine composition of the treatment hepatitis A of the present embodiment, includes the component of following weight proportion：
Wild 10 grams of cigarette, 10 grams of Artemisia stelleriana, 10 grams of wild leek, 10 grams of babysbreath, 20 grams of giant knotweed, 10 grams of Common Goldenrod Herb, 45 grams of leftovers.
Preparation method and usage and dosage are the same as embodiment 1.
Therapeutic effect is as follows：
Receive treatment patient：113 people；It is effective：84 people, accounting 74%；Effectively：20 people, accounting 18%；It is invalid：9 people, accounting 8%.
Wherein, it is effective to refer to：The state of an illness is controlled, and every physical signs is qualified, can the normal life as mediocrity.
Effectively refer to：For patient after taking the Chinese medicine composition of the present invention, every physical signs obtains certain improvement,
But it cannot still live as normal person, it is also necessary to continue to take related drugs.
It is invalid to refer to：Before and after the Chinese medicine composition for taking the present invention, conditions of patients does not have significant change.
The patient of every traditional Chinese medicine composition for treating for receiving the present invention, does not all produce other injuries during reflection medication
And pain.
It is the detailed description of effective patient's treatment below：
XX is opened, Zhejiang Fenghua, at 62 years old age, inconvenient walking, urine is very yellow, weak all over, face jaundice, eyeball jaundice belly
Distending pain, in hepatitis A late period, medication seven days one month, the state of an illness is controlled, and every physical signs is qualified.
Wu XX, inner people from town, at 15 years old age, face jaundice, weak all over, nausea kecks, hepatitis A mid-term, medication one
Month, the state of an illness is controlled, and every physical signs is qualified.
To XX, Longshan Nei Xi village people, at 22 years old age, eyeball jaundice, complexion is dark yellow, weak all over, feels bad very much, does not relax
Clothes, belly distending pain, hepatitis A early stage, medication 27 days, the state of an illness is controlled, and every physical signs is qualified.
XX is opened, inner people from town, at 28 years old age, physical fatigue is powerless, eyeball jaundice, complexion jaundice, urine jaundice, medication 26
My god, hepatitis A mid-term, the state of an illness is controlled, and every physical signs is qualified.
White XX, Sichuan people from Chengdu, at 45 years old age, physical fatigue is powerless, eyeball jaundice, face jaundice, dark yellow unglazed, urine
Dark yellow, hepatitis A mid-term, medication 15 days one month, the state of an illness is controlled, and every physical signs is qualified.
It is understood that the principle that embodiment of above is intended to be merely illustrative of the present and the exemplary implementation that uses
Mode, but the present invention is not limited thereto.For those skilled in the art, the essence of the present invention is not being departed from
In the case of refreshing and essence, various changes and modifications can be made therein, these variations and modifications are also considered as protection scope of the present invention.
Claims (10)
1. a kind of Chinese medicine composition for treating hepatitis A, it is characterised in that include the component of following weight proportion：
Wild 8-12 grams of cigarette, sub- 8-12 grams of Artemisia stelleriana, 8-12 grams of wild leek, 8-12 grams of babysbreath, 8-12 grams of giant knotweed, Common Goldenrod Herb 8-12
Gram, 5-80 grams of leftovers.
2. the Chinese medicine composition for the treatment of hepatitis A according to claim 1, it is characterised in that：Wild 9-11 grams of cigarette.
3. the Chinese medicine composition for the treatment of hepatitis A according to claim 1 or 2, it is characterised in that：Sub- 9-11 grams of Artemisia stelleriana.
4. the Chinese medicine composition for the treatment of hepatitis A according to claim 1 or 2, it is characterised in that：9-11 grams of wild leek.
5. the Chinese medicine composition for the treatment of hepatitis A according to claim 1 or 2, it is characterised in that：9-11 grams of babysbreath.
6. the Chinese medicine composition for the treatment of hepatitis A according to claim 1 or 2, it is characterised in that：18-22 grams of giant knotweed.
7. the Chinese medicine composition for the treatment of hepatitis A according to claim 1 or 2, it is characterised in that：9-11 grams of Common Goldenrod Herb.
8. the Chinese medicine composition for the treatment of hepatitis A according to claim 1 or 2, it is characterised in that：10-60 grams of leftovers.
9. the Chinese medicine composition for the treatment of hepatitis A according to claim 1, it is characterised in that include the group of following weight proportion
Point：
Wild 10 grams of cigarette, 10 grams of Artemisia stelleriana, 10 grams of wild leek, 10 grams of babysbreath, 20 grams of giant knotweed, 10 grams of Common Goldenrod Herb, 45 grams of leftovers.
10. a kind of preparation method of the Chinese medicine composition for the treatment of hepatitis A as described in claim 1-9 any claims, it is special
Sign is, first weighs each raw material by predetermined weight proportioning, then grinds respectively, is uniformly mixed, you can.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711341897.4A CN107929592A (en) | 2017-12-14 | 2017-12-14 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711341897.4A CN107929592A (en) | 2017-12-14 | 2017-12-14 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107929592A true CN107929592A (en) | 2018-04-20 |
Family
ID=61944323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711341897.4A Pending CN107929592A (en) | 2017-12-14 | 2017-12-14 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107929592A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127651A (en) * | 1995-01-23 | 1996-07-31 | 朱树新 | Method for producing "Ganyanmie" Chinese patent medicine for treating hepatitis and products thereby |
| CN101357184A (en) * | 2008-08-22 | 2009-02-04 | 朱秀进 | Chinese traditional medicine for treating hepatosis and preparation method thereof |
| CN105106909A (en) * | 2015-09-25 | 2015-12-02 | 孙志军 | Traditional Chinese medicine composition for treating hepatitis A |
-
2017
- 2017-12-14 CN CN201711341897.4A patent/CN107929592A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127651A (en) * | 1995-01-23 | 1996-07-31 | 朱树新 | Method for producing "Ganyanmie" Chinese patent medicine for treating hepatitis and products thereby |
| CN101357184A (en) * | 2008-08-22 | 2009-02-04 | 朱秀进 | Chinese traditional medicine for treating hepatosis and preparation method thereof |
| CN105106909A (en) * | 2015-09-25 | 2015-12-02 | 孙志军 | Traditional Chinese medicine composition for treating hepatitis A |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20200024185A (en) | Pharmaceutical and food composition for treating or alleviating influenza a | |
| CN101700301A (en) | Traditional Chinese medicine composition for treating blue ear diseases and preparation method thereof | |
| CN100536901C (en) | Chinese medicine for treating burn, scald and frostbite | |
| CN103405739A (en) | Medicine for treating infant suppurative tonsillitis | |
| CN103977194A (en) | Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot | |
| CN106511740A (en) | Radix ginseng-containing health product and preparation method therefor | |
| CN107929592A (en) | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof | |
| CN102406711A (en) | Medicament for treating diabetes | |
| CN103610685A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN107617018B (en) | Pharmaceutical composition for treating livestock dermatitis herpetiformis and application method thereof | |
| US10959450B2 (en) | Food composition for relieving symptoms of allergic and autoimmune diseases | |
| CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
| CN103893436B (en) | A kind of externally applied drug for treating rheumatism | |
| CN107737173A (en) | A kind of Chinese medicine preparation for treating diabete peripheral herve pathology and preparation method thereof | |
| CN108939011A (en) | A kind of Chinese herbal medicine formula for the treatment of cancer | |
| Mohammadnezhadostad et al. | Investigation Of Nursing And Medical Services In Patients With Diabetes, Abdominal Pain And High Blood Pressure. | |
| CN105708984A (en) | Tibetan medicine composition for treating diarrhea of sheep and application of Tibetan medicine composition | |
| CN101879187A (en) | Lamina burn and scald plaster for expelling pus and promoting granulation and preparation method thereof | |
| CN105250898A (en) | Compound Tibetan medicine with efficacy of detoxification and liver protection | |
| CN103479916B (en) | Prevent and treat Chinese medicine composition of Schweineseuche and preparation method thereof | |
| CN110384744A (en) | A kind of composition and preparation method treated scytitis and promote wound healing | |
| CN107260664A (en) | A kind of compound flunixin meglumine injection and preparation method thereof | |
| CN106491789A (en) | A kind of treat externally applied ointment of burn and scald and preparation method thereof | |
| CN107693589A (en) | A kind of medicine for treating hepatitis B and preparation method thereof | |
| CN111214633A (en) | Formula for treating infectious hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180420 |
|
| RJ01 | Rejection of invention patent application after publication |